Journal for ImmunoTherapy of Cancer (Nov 2020)
364 A personal neoantigen vaccine NEO-PV-01 in combination with chemotherapy and pembrolizumab induces broad de novo immune responses in first line, non-squamous NSCLC
- Saiama Waqar,
- Mark Awad,
- Ramaswamy Govindan,
- David Spigel,
- Richard Gaynor,
- Edward Garon,
- Aaron Lisberg,
- Melissa Moles,
- Jennifer Tepper,
- April Lamb,
- Amy Wanamaker,
- Zakaria Khondker,
- John Srouji,
- Jesse Dong,
- Asaf Poran,
- Kristen Balogh,
- Meghan Bushway,
- Mark DeMario,
- Lakshmi Srinivasan
Affiliations
- Saiama Waqar
- Aff11 grid.4367.60000000123557002Washington University St. Louis WA USA
- Mark Awad
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Ramaswamy Govindan
- Aff2 0000 0001 2355 7002grid.4367.6Division of OncologyWashington University 63110 St Louis MO USA
- David Spigel
- Sarah Cannon Research Institute, Nashville, Tennessee, USA
- Richard Gaynor
- 1BioNTech US Inc., Cambridge, MA, USA
- Edward Garon
- 3UCLA Medical Center, Santa Monica, CA, USA
- Aaron Lisberg
- 3UCLA Medical Center, Santa Monica, CA, USA
- Melissa Moles
- 5BioNTech US, Cambridge, MA, USA
- Jennifer Tepper
- 5BioNTech US, Cambridge, MA, USA
- April Lamb
- 5BioNTech US, Cambridge, MA, USA
- Amy Wanamaker
- 5BioNTech US, Cambridge, MA, USA
- Zakaria Khondker
- 5BioNTech US, Cambridge, MA, USA
- John Srouji
- 5BioNTech US, Cambridge, MA, USA
- Jesse Dong
- 5BioNTech US, Cambridge, MA, USA
- Asaf Poran
- 5BioNTech US, Cambridge, MA, USA
- Kristen Balogh
- 5BioNTech US, Cambridge, MA, USA
- Meghan Bushway
- 5BioNTech US, Cambridge, MA, USA
- Mark DeMario
- 5BioNTech US, Cambridge, MA, USA
- Lakshmi Srinivasan
- 5BioNTech US, Cambridge, MA, USA
- DOI
- https://doi.org/10.1136/jitc-2020-SITC2020.0364
- Journal volume & issue
-
Vol. 8,
no. Suppl 3
Abstract
No abstracts available.
